Bio-rad Laboratories, Inc. Earnings

Bio-rad Laboratories, Inc.’s revenue jumped 2.06% since last year same period to $651.6Mn in the Q2 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 11.31% jump in its revenue since last 3-months.

Bio-rad Laboratories, Inc.’s net profit jumped 114.68% since last year same period to $317.8Mn in the Q2 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 396.56% jump in its net profits since last 3-months.

Bio-rad Laboratories, Inc.’s net profit margin jumped 114.38% since last year same period to 48.77% in the Q2 2025. On a quarterly growth basis, Bio-rad Laboratories, Inc. has generated 346.11% jump in its net profit margins since last 3-months.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.97 - a 11.93% jump from last quarter’s estimates.

Bio-rad Laboratories, Inc.’s earning per share (EPS) estimates for the current year stand at 1.97.

Bio-rad Laboratories, Inc.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Bio-rad Laboratories, Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.